Kiora Pharmaceuticals Advances Key Clinical Programs
ENCINITAS, Calif., August 7, 2026 Kiora Pharmaceuticals reported second quarter 2026 financial results while highlighting continued progress across its...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ENCINITAS, Calif., August 7, 2026 Kiora Pharmaceuticals reported second quarter 2026 financial results while highlighting continued progress across its...
LUND, Sweden, August 7, 2026 BioInvent International AB announced that the U.S. Food and Drug Administration (FDA) has granted...
New York, August 6, 2026 WindRose Health Investors, LLC has completed the recapitalization of Verified Clinical Trials, LLC (VCT),...
Philadelphia, Pennsylvania, August 3, 2026 Signant Health announced the launch of Forecasting & Planning Assistâ„¢, a purpose-built agentic AI...
BAAR, Switzerland, July 29, 2026 Evinova, an AI-native clinical development technology company within the AstraZeneca group, has entered into...
WALTHAM, Mass., July 29, 2026 TScan Therapeutics announced that the first patient has been dosed with TSC-101 in the...
DUBLIN, Ireland, July 28, 2026 DUBLIN, Ireland, July 28, 2026 – ICON plc announced a multi-year strategic collaboration with...
BOSTON, July 27, 2026 HoneyNaps has officially registered as a Contract Research Organization (CRO) with the Korea National Enterprise...
ROCKVILLE, Md. & SHANGHAI, July 20, 2026 AbelZeta Pharma, Inc. has achieved a significant regulatory milestone after the European...
SAN ANTONIO, July 20, 2026 Valion Bio, Inc. has announced a significant clinical development milestone after Sheba Medical Center,...
